Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Herman Soto-Molina"'
Autor:
Oscar Arrieta, Rodrigo Catalán, Silvia Guzmán-Vazquez, Feliciano Barrón, Luis Lara-Mejía, Herman Soto-Molina, Maritza Ramos-Ramírez, Diana Flores-Estrada, Jaime de la Garza
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-8 (2020)
Abstract Background Tyrosine-kinase inhibitors (TKIs) have become the cornerstone treatment of patients with non-small cell lung cancer that harbor oncogenic EGFR mutations. The counterpart of these drugs is the financial burden that they impose, whi
Externí odkaz:
https://doaj.org/article/a271e89161d143bbbc8a2934bd76b46f
Autor:
Oscar Arrieta, Wendy Muñoz-Montaño, Sae Muñiz-Hernández, Saul Campos, Rodrigo Catalán, Herman Soto-Molina, Silvia Guzmán Vázquez, Osvaldo Díaz-Álvarez, Victor Martínez-Pacheco, Jenny G. Turcott, Maritza Ramos-Ramírez, Luis Cabrera-Miranda, Feliciano Barrón, Andrés F. Cardona
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundMalignant pleural mesothelioma (MPM) is rare and aggressive neoplasia, with a poor prognosis; furthermore, the monetary cost of its treatment represents a major challenge for many patients. The economic burden this malignancy imposes is und
Externí odkaz:
https://doaj.org/article/1fc075ad32024d69bbc124abf3faa686
Autor:
Maria del Carmen Cano Salas, José Luis Miguel Reyes, Karen Sánchez Trejo, Erika del Carmen López Estrada, Jorge Salas Hernández, Monserrat Evelia Arroyo Rojas, Mauricio Castañeda Valdivia, Monserrat Escobar Preciado, Silvia Guzmán Vázquez, Sergio Ricardo García-García, Herman Soto Molina
Publikováno v:
Revista Alergia México, Vol 71, Iss 1 (2024)
Background. In Mexico, asthma is one of the top twenty causes of disease with 254,713 new cases reported in 2019. According to Phase 3 of the International Study of Asthma and Allergies in Childhood, the prevalence of asthma ranged from 5 to 14% in 6
Externí odkaz:
https://doaj.org/article/5dc897bbd1c84ed7b68c88b51e5a3cb7
Autor:
Karen Sánchez Trejo, Eduardo Soei Sarmiento Sánchez, Yazmin Escobar Juárez, Humberto García-Aguilar, Silvia Guzmán Vázquez, Herman Soto Molina, Katiria Itzel Juárez Vásquez
Publikováno v:
Journal of Comparative Effectiveness Research. 10:1251-1257
Aim: The objective of this study was to evaluate the healthcare costs and resource utilization of pediatric pulmonary arterial hypertension management at a third-level hospital in Mexico. Methods: A retrospective cohort study was conducted in a pedia
Autor:
Leslie Pérez Ruiz, Mauricio Mijaíl Rodríguez Mendoza, Herman Soto Molina, Yaima Galán Álvarez, Carmen Elena Viada González, Manuel Miguel Collazo Herrera
Publikováno v:
VacciMonitor, Vol 29, Iss 1, Pp 14-21 (2020)
En Cuba, el cáncer es la segunda causa de muerte con 24.902 defunciones en el 2018; de ellas, 795 fueron por tumores de laringe y 826 por tumores de labio, cavidad bucal y faringe. El anticuerpo monoclonal nimotuzumab (CIMAher®) está registrado co
Autor:
Osvaldo Díaz-Álvarez, Minerva López-Ruiz, Silvia Guzmán-Vazquez, Herman Soto-Molina, Yareli O. Buendía-López
Publikováno v:
Revista Mexicana de Neurociencia. 22
Autor:
Diana Flores-Estrada, Silvia Guzmán-Vazquez, Maritza Ramos-Ramírez, Rodrigo Catalán, Luis Lara-Mejía, Herman Soto-Molina, Oscar Arrieta, Jaime de la Garza, Feliciano Barrón
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-8 (2020)
BMC Cancer
BMC Cancer
Background Tyrosine-kinase inhibitors (TKIs) have become the cornerstone treatment of patients with non-small cell lung cancer that harbor oncogenic EGFR mutations. The counterpart of these drugs is the financial burden that they impose, which often
Autor:
Amin Cervantes-Arriaga, Adib Jorge de Saráchaga, Mayela Rodríguez-Violante, Maribel Márquez-Cruz, Herman Soto-Molina, Rodrigo Llorens-Arenas, Juan Pablo Díaz-Martínez
Publikováno v:
Expert Review of Pharmacoeconomics & Outcomes Research. 16:97-102
Parkinson’s disease (PD) is the second most common neurodegenerative disease. There are no clinical trials comparing all available pharmacological therapies for the treatment of early PD. The objective of this review is to indirectly analyze the ef
Autor:
Amílcar Azamar Alonso, Aleida Azamar Alonso, Andrés Ernesto Constanzo Sandoval, Cecilia Fernández del Valle Laisequilla, Herman Soto Molina, Juan Gerardo Reyes García
Publikováno v:
PharmacoEconomics Spanish Research Articles. 13:9-15
Objetivo Realizar una evaluacion economica completa a traves de un analisis de coste-efectividad del triple esquema de erradicacion frente al no tratamiento profilactico como estrategia para evitar complicaciones gastroduodenales graves en pacientes
Autor:
Laura, Cortés-Sanabria, Guillermina, Álvarez-Santana, Claudia Nelly, Orozco-González, Herman, Soto-Molina, Héctor Ramón, Martínez-Ramírez, Alfonso Martín, Cueto-Manzano
Publikováno v:
Revista medica del Instituto Mexicano del Seguro Social. 55(Suppl 2)
In Mexico, as in other parts of the world, end-stage renal disease (ESRD) constitutes a public health problem associated with high morbidity, mortality, costs and a diminished quality of life. The Instituto Mexicano del Seguro Social (IMSS) attends t